ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 40 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $25,000 | -99.2% | 25,000 | -99.1% | 0.00% | – |
| Q4 2020 | $3,106,000 | -21.7% | 2,874,000 | -26.7% | 0.00% | -100.0% |
| Q1 2020 | $3,967,000 | -57.5% | 3,920,000 | -52.0% | 0.00% | 0.0% |
| Q4 2019 | $9,336,000 | +89.8% | 8,160,000 | +89.2% | 0.00% | 0.0% |
| Q3 2019 | $4,919,000 | +2187.9% | 4,313,000 | +2269.8% | 0.00% | – |
| Q2 2019 | $215,000 | -86.9% | 182,000 | -85.0% | 0.00% | – |
| Q1 2019 | $1,636,000 | +23271.4% | 1,210,000 | +17185.7% | 0.00% | – |
| Q4 2018 | $7,000 | +16.7% | 7,000 | +16.7% | 0.00% | – |
| Q3 2018 | $6,000 | 0.0% | 6,000 | 0.0% | 0.00% | – |
| Q2 2018 | $6,000 | 0.0% | 6,000 | 0.0% | 0.00% | – |
| Q1 2018 | $6,000 | 0.0% | 6,000 | 0.0% | 0.00% | – |
| Q4 2017 | $6,000 | 0.0% | 6,000 | 0.0% | 0.00% | – |
| Q3 2017 | $6,000 | 0.0% | 6,000 | 0.0% | 0.00% | – |
| Q2 2017 | $6,000 | +500.0% | 6,000 | +500.0% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | -98.5% | 1,000 | -98.6% | 0.00% | – |
| Q3 2016 | $65,000 | -97.6% | 70,000 | -98.2% | 0.00% | -100.0% |
| Q2 2016 | $2,714,000 | +90366.7% | 3,840,000 | +127900.0% | 0.00% | – |
| Q1 2016 | $3,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|